CAR T cells take on precancers

作者:

摘要 / Abstract

CAR T cell therapy can induce deep responses but also severe toxicities in patients with smoldering myeloma, an asymptomatic cancer precursor; given the potential risks and benefits, its success depends on careful patient selection.

同行评议区

登录学者账户后即可在此处发表评述或点赞。

立即登录

暂无评议记录。